Satya Srinivas Mulukutla

Satya Srinivas Mulukutla

Active Director Designated Partner DIN 06588666
DIN 06588666 First appointment May 2013 Primary industry Real Estate and Construction
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 5 active board seats
Past companies 2 historical roles
Total affiliations 7 Since May 2013
Shareholding value β€’β€’β€’β€’ Premium profile

About Satya Srinivas Mulukutla

Data last updated:

Satya Srinivas Mulukutla is a Designated Partner at Mulukutla Real Estates Llp (since 2019), Managing Director at Mjs Life Sciences Private Limited (since 2019) and Managing Director at Mjs Pharmaceuticals Private Limited (since 2019), and holds 2 more current directorships. The companies operate in Real Estate and Construction, Chemicals and Information Technology. Earlier, Satya Srinivas Mulukutla was a Managing Director at Sls Pharmaceuticals Private Limited (from 2013) and Managing Director at Sls Reagents Private Limited (from 2013).

DIN 06588666
Primary Designation Designated Partner
Industry Real Estate and Construction
First Appointment 28 May 2013
Oldest Company Age 13 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner25 Apr 20192019Active
Mjs Life Sciences Private Limited U24110TG2019PTC129892
Managing Director25 Jan 20192019Active
Mjs Pharmaceuticals Private Limited U24299TG2019PTC129878
Managing Director25 Jan 20192019Active
Mjs Infotech Private Limited U72900TG2019PTC129658
Managing Director10 Jan 20192019Active
Sls Life Sciences Private Limited U24303TG2018PTC128751
Managing Director04 Dec 20182018Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sls Pharmaceuticals Private Limited U24232TG2013PTC087974
Managing Director28 May 20132013₹4.30 Cr (FY 2018)Strike Off
Sls Reagents Private Limited U24233TG2013PTC091158
Managing Director21 Nov 20132013₹2.44 Cr (FY 2018)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Satya Srinivas Mulukutla

Directorship timeline

Open interactive timeline →
Mulukutla Real Estates Llp
Mjs Life Sciences Private Limited
Sls Pharmaceuticals Private Limited
Sls Reagents Private Limited
Premium access

Shareholding and investment profile for Satya Srinivas Mulukutla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Satya Srinivas Mulukutla

Satya Srinivas Mulukutla currently holds 5 directorships: Mulukutla Real Estates Llp (Designated Partner, since 25 Apr 2019); Mjs Life Sciences Private Limited (Managing Director, since 25 Jan 2019); Mjs Pharmaceuticals Private Limited (Managing Director, since 25 Jan 2019); Mjs Infotech Private Limited (Managing Director, since 10 Jan 2019); Sls Life Sciences Private Limited (Managing Director, since 04 Dec 2018).

Satya Srinivas Mulukutla was first appointed on 28 May 2013 as Managing Director at Sls Pharmaceuticals Private Limited. The most recent appointment on record is 25 Apr 2019 at Mulukutla Real Estates Llp.

Satya Srinivas Mulukutla held 2 earlier board appointments: Sls Pharmaceuticals Private Limited (Managing Director, from 28 May 2013); Sls Reagents Private Limited (Managing Director, from 21 Nov 2013).

The current boards of Satya Srinivas Mulukutla's companies include Pavan Bhasker Jagannadham Mulukutla (Mulukutla Real Estates Llp), Nudurumati Naga Siva Kumar (Mjs Life Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available